Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study-Reference-Cited by-同舟云学术

Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study

Published:2023-01 Issue:1 Volume:8 Page:31-42
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Atia Ohad,Shavit-Brunschwig Zivia,Mould Diane R,Stein Ronen,Matar Manar,Aloi Marina,Ledder Oren,Focht Gili,Urlep Darja,Hyams Jeffrey,Broide Efrat,Weiss Batia,Levine Jeremiah,Russell Richard K,Turner Dan

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference35 articles.

1. Improved outcomes of pediatric and adult Crohn's disease and association with emerging use of biologics - a nationwide study from the epi-IIRN;Atia;J Crohn's Colitis,2021

2. Colectomy rates did not decrease in paediatric- and adult-onset ulcerative colitis during the biologics era: a nationwide study from the epi-IIRN;Atia;J Crohn's Colitis,2021

3. Presentation and progression of childhood-onset inflammatory bowel disease in northern Stockholm County;Malmborg;Inflamm Bowel Dis,2015

4. Inflammatory bowel disease in young people: the case for transitional clinics;Goodhand;Inflamm Bowel Dis,2010

5. Risk of cancer in pediatric-onset inflammatory bowel diseases: a nation-wide study from the epi-IIRN;Atia;J Crohn's Colitis,2022

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents;Saudi Journal of Gastroenterology;2024-08-30

2. Therapeutic options for children and young people with moderate-to-severe ulcerative colitis;Frontline Gastroenterology;2024-07-13

3. Role of Clinical Pharmacology in Diversity and Inclusion in Global Drug Development: Current Practices and Industry Perspectives: White Paper;Clinical Pharmacology & Therapeutics;2024-07-07

4. Updates In The Management Of Pediatric Inflammatory Bowel Disease;Canadian IBD Today;2024-06-05

5. Novel pharmacological developments in the management of paediatric inflammatory bowel disease;Journal of Paediatrics and Child Health;2024-06